MDT
Medtronic PLC
NYSE: MDT · HEALTHCARE · MEDICAL DEVICES
$80.20
-0.16% today
Updated 2026-06-12
Market cap
$94.69B
P/E ratio
20.60
P/S ratio
2.67x
EPS (TTM)
$3.58
Dividend yield
3.83%
52W range
$73 – $105
Volume
10.3M
Medtronic PLC (MDT) Insider transactions
Net insider activity
Net selling (203,584 shares)
Buy transactions
31
Sell transactions
69
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-26 | WALTER, MATTHEW R. | SVP, Chief HR Officer | Sale | 8,449 | — | — |
| 2026-05-26 | WALTER, MATTHEW R. | SVP, Chief HR Officer | Buy | 9,149 | — | — |
| 2026-05-26 | WALL, BRETT A. | EVP & Pres Neuroscience | Sale | 24,214 | — | — |
| 2026-05-26 | WALL, BRETT A. | EVP & Pres Neuroscience | Buy | 26,907 | — | — |
| 2026-05-26 | MARTHA, GEOFFREY | Director, Chairman and CEO | Sale | 85,461 | — | — |
| 2026-05-26 | MARTHA, GEOFFREY | Director, Chairman and CEO | Buy | 94,963 | — | — |
| 2026-05-26 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Sale | 17,093 | — | — |
| 2026-05-26 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Buy | 18,994 | — | — |
| 2026-05-26 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 14,517 | — | — |
| 2026-05-26 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Buy | 15,195 | — | — |
| 2026-05-26 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Sale | 1,621 | — | — |
| 2026-05-26 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Buy | 1,712 | — | — |
| 2026-05-01 | WALTER, MATTHEW R. | SVP, Chief HR Officer | Sale | 35 | $80.00 | $2800.00 |
| 2026-04-28 | POWELL, KENDALL J | Director | Sale | 207 | $81.90 | $16953.30 |
| 2026-04-28 | NABEL, ELIZABETH G | Director | Sale | 207 | $81.90 | $16953.30 |
| 2026-04-28 | LOFTON, KEVIN E | Director | Sale | 207 | $81.90 | $16953.30 |
| 2026-04-28 | LEWIS, GREGORY P | Director | Sale | 207 | $81.90 | $16953.30 |
| 2026-04-28 | HOGAN, RANDALL J | Director | Sale | 207 | $81.90 | $16953.30 |
| 2026-04-28 | FONSECA, LIDIA | Director | Sale | 207 | $81.90 | $16953.30 |
| 2026-04-28 | DONNELLY, SCOTT C | Director | Sale | 207 | $81.90 | $16953.30 |
| 2026-04-28 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Sale | 318 | $81.90 | $26044.20 |
| 2026-04-28 | ARNOLD, CRAIG | Director | Sale | 207 | $81.90 | $16953.30 |
| 2026-04-27 | POWELL, KENDALL J | Director | Buy | 2,111 | — | — |
| 2026-04-27 | NABEL, ELIZABETH G | Director | Buy | 2,111 | — | — |
| 2026-04-27 | LOFTON, KEVIN E | Director | Buy | 2,111 | — | — |
| 2026-04-27 | LEWIS, GREGORY P | Director | Buy | 2,111 | — | — |
| 2026-04-27 | LEE, JOON SUP | Director | Buy | 1,803 | — | — |
| 2026-04-27 | JELLISON, WILLIAM R | Director | Buy | 1,444 | — | — |
| 2026-04-27 | HOGAN, RANDALL J | Director | Buy | 2,111 | — | — |
| 2026-04-27 | GROETELAARS, JOHN P | Director | Buy | 1,444 | — | — |
| 2026-04-27 | FONSECA, LIDIA | Director | Buy | 2,111 | — | — |
| 2026-04-27 | DONNELLY, SCOTT C | Director | Buy | 2,111 | — | — |
| 2026-04-27 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Buy | 1,508 | — | — |
| 2026-04-27 | ARNOLD, CRAIG | Director | Buy | 2,111 | — | — |
| 2026-03-03 | PIETON, THIERRY | EVP & Chief Financial Officer | Sale | 2,976 | $96.71 | $287808.96 |
| 2026-02-20 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Sale | 340 | — | — |
| 2026-02-19 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 30,568 | — | — |
| 2026-02-19 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 19,923 | — | — |
| 2026-02-19 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 385 | — | — |
| 2026-02-19 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 30,568 | $97.66 | $2.99M |
| 2026-02-19 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Buy | 19,923 | $87.76 | $1.75M |
| 2026-02-19 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 19,255 | $97.77 | $1.88M |
| 2026-02-19 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 1,648 | $97.86 | $161273.28 |
| 2026-02-19 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 668 | $97.83 | $65347.10 |
| 2026-02-19 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 385 | $97.82 | $37660.70 |
| 2026-01-29 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Sale | 148 | $101.00 | $14948.00 |
| 2025-12-15 | WALL, BRETT A. | EVP & Pres Neuroscience | Sale | 439 | $99.87 | $43842.93 |
| 2025-12-15 | MARTHA, GEOFFREY | Director, Chairman and CEO | Sale | 1,564 | $99.87 | $156196.68 |
| 2025-12-15 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Sale | 1,371 | $99.87 | $136921.77 |
| 2025-12-05 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 1,702 | $101.36 | $172514.72 |
| 2025-11-20 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Sale | 170 | — | — |
| 2025-11-19 | SMITH, GREGORY L | EVP Global Ops & Supply Chain | Sale | 24,186 | $101.93 | $2.47M |
| 2025-11-19 | SMITH, GREGORY L | EVP Global Ops & Supply Chain | Sale | 1,995 | $102.03 | $203549.85 |
| 2025-11-19 | SMITH, GREGORY L | EVP Global Ops & Supply Chain | Sale | 1,942 | $101.99 | $198064.58 |
| 2025-11-19 | SMITH, GREGORY L | EVP Global Ops & Supply Chain | Sale | 825 | $102.04 | $84183.00 |
| 2025-11-19 | SMITH, GREGORY L | EVP Global Ops & Supply Chain | Sale | 500 | $102.08 | $51040.00 |
| 2025-11-19 | SMITH, GREGORY L | EVP Global Ops & Supply Chain | Sale | 325 | $102.06 | $33169.50 |
| 2025-11-19 | SMITH, GREGORY L | EVP Global Ops & Supply Chain | Sale | 227 | $102.05 | $23165.35 |
| 2025-09-03 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 8,405 | $91.58 | $769729.90 |
| 2025-09-03 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 200 | $91.59 | $18318.00 |
| 2025-08-25 | JELLISON, WILLIAM R | Director | Buy | 2,500 | $92.37 | $230925.00 |
| 2025-08-22 | JELLISON, WILLIAM R | Director | Buy | 2,500 | $92.73 | $231825.00 |
| 2025-08-20 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Sale | 1,052 | $93.22 | $98067.44 |
| 2025-08-01 | WALTER, MATTHEW R. | SVP, Chief HR Officer | Sale | 963 | — | — |
| 2025-08-01 | WALTER, MATTHEW R. | SVP, Chief HR Officer | Sale | 2,179 | — | — |
| 2025-08-01 | WALTER, MATTHEW R. | SVP, Chief HR Officer | Buy | 2,179 | — | — |
| 2025-08-01 | WALTER, MATTHEW R. | SVP, Chief HR Officer | Buy | 963 | $78.00 | $75114.00 |
| 2025-08-01 | WALTER, MATTHEW R. | SVP, Chief HR Officer | Sale | 879 | $89.34 | $78529.86 |
| 2025-08-01 | WALTER, MATTHEW R. | SVP, Chief HR Officer | Sale | 667 | $89.34 | $59589.78 |
| 2025-08-01 | WALTER, MATTHEW R. | SVP, Chief HR Officer | Sale | 364 | $89.34 | $32519.76 |
| 2025-08-01 | WALL, BRETT A. | EVP & Pres Neuroscience | Sale | 15,249 | — | — |
| 2025-08-01 | WALL, BRETT A. | EVP & Pres Neuroscience | Buy | 15,249 | — | — |
| 2025-08-01 | WALL, BRETT A. | EVP & Pres Neuroscience | Sale | 7,744 | $89.34 | $691848.96 |
| 2025-08-01 | WALL, BRETT A. | EVP & Pres Neuroscience | Sale | 3,850 | $89.34 | $343959.00 |
| 2025-08-01 | SMITH, GREGORY L | EVP Global Ops & Supply Chain | Sale | 11,328 | — | — |
| 2025-08-01 | SMITH, GREGORY L | EVP Global Ops & Supply Chain | Buy | 11,328 | — | — |
| 2025-08-01 | SMITH, GREGORY L | EVP Global Ops & Supply Chain | Sale | 4,458 | $89.34 | $398277.72 |
| 2025-08-01 | SMITH, GREGORY L | EVP Global Ops & Supply Chain | Sale | 2,656 | $89.34 | $237287.04 |
| 2025-08-01 | MARTHA, GEOFFREY | Director, Chairman and CEO | Sale | 40,600 | — | — |
| 2025-08-01 | MARTHA, GEOFFREY | Director, Chairman and CEO | Sale | 57,724 | — | — |
| 2025-08-01 | MARTHA, GEOFFREY | Director, Chairman and CEO | Buy | 57,724 | — | — |
| 2025-08-01 | MARTHA, GEOFFREY | Director, Chairman and CEO | Buy | 40,600 | $78.00 | $3.17M |
| 2025-08-01 | MARTHA, GEOFFREY | Director, Chairman and CEO | Sale | 37,798 | $89.34 | $3.38M |
| 2025-08-01 | MARTHA, GEOFFREY | Director, Chairman and CEO | Sale | 26,323 | $89.34 | $2.35M |
| 2025-08-01 | MARTHA, GEOFFREY | Director, Chairman and CEO | Sale | 13,054 | $89.34 | $1.17M |
| 2025-08-01 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Sale | 3,126 | — | — |
| 2025-08-01 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Sale | 6,535 | — | — |
| 2025-08-01 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Buy | 6,535 | — | — |
| 2025-08-01 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Sale | 3,158 | $89.34 | $282135.72 |
| 2025-08-01 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Buy | 3,126 | $78.00 | $243828.00 |
| 2025-08-01 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Sale | 2,864 | $89.34 | $255869.76 |
| 2025-08-01 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Sale | 1,741 | $89.34 | $155540.94 |
| 2025-08-01 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 10,457 | — | — |
| 2025-08-01 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Buy | 10,457 | — | — |
| 2025-08-01 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 4,659 | $89.34 | $416235.06 |
| 2025-08-01 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 2,896 | $89.34 | $258728.64 |
| 2025-08-01 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Sale | 214 | — | — |
| 2025-08-01 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Sale | 246 | — | — |
| 2025-08-01 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Sale | 58 | — | — |
| 2025-08-01 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Buy | 246 | — | — |
Frequently asked questions
Are MDT insiders buying or selling?
Over the transactions on record, MDT insiders have been net sellers, with about $20.16M in stock sold across 69 sales, against 6 open-market purchases.
Does insider selling at MDT mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which MDT insiders are selling the most?
Recent selling is concentrated in a few names. MARTHA, GEOFFREY accounts for the largest share on record, with about $7.05M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.